KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Short term Debt (2020 - 2021)

Ginkgo Bioworks Holdings' Short term Debt history spans 2 years, with the latest figure at $631638.0 for Q2 2021.

  • For Q2 2021, Short term Debt changed N/A year-over-year to $631638.0; the TTM value through Jun 2021 reached $631638.0, changed N/A, while the annual FY2020 figure was $156333.0, N/A changed from the prior year.
  • Short term Debt reached $631638.0 in Q2 2021 per DNA's latest filing, up from $156333.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $631638.0 in Q2 2021 to a low of $156333.0 in Q4 2020.